If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yi-Min Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 31 Similar Profiles
Histone Deacetylase Inhibitors Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Histone Deacetylases Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Tubulin Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Inhibitory Concentration 50 Medicine & Life Sciences
Tissue Inhibitor of Metalloproteinase-3 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2019 2020


Liu, Y.


Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 2012 2019

  • 330 Citations
  • 11 h-Index
  • 19 Article
  • 1 Review article
5 Citations (Scopus)

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

Lai, M. J., Ojha, R., Lin, M. H., Liu, Y. M., Lee, H. Y., Lin, T. E., Hsu, K. C., Chang, C. Y., Chen, M. C., Nepali, K., Chang, J. Y. & Liou, J. P., Jan 15 2019, In : European Journal of Medicinal Chemistry. 162, p. 612-630 19 p.

Research output: Contribution to journalArticle

Histone Deacetylases
Inhibitory Concentration 50
3 Citations (Scopus)
Urinary Bladder Neoplasms
Antineoplastic Agents
G1 Phase
Ovarian Neoplasms
Open Access
Tissue Inhibitor of Metalloproteinase-3
Colorectal Neoplasms
Neoplasm Metastasis
2 Citations (Scopus)

1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma

Liu, Y. M., HuangFu, W. C., Huang, H. L., Wu, W. C., Chen, Y. L., Yen, Y., Huang, H. L., Nien, C. Y., Lai, M. J., Pan, S. L. & Liou, J. P., Nov 10 2017, In : European Journal of Medicinal Chemistry. 140, p. 84-91 8 p.

Research output: Contribution to journalArticle

Ubiquitin-Protein Ligases
Multiple Myeloma
Lead compounds
3 Citations (Scopus)

An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells

Chao, M. W., Huang, H. L., HuangFu, W. C., Hsu, K. C., Liu, Y. M., Wu, Y. W., Lin, C. F., Chen, Y. L., Lai, M. J., Lee, H. Y., Liou, J. P., Teng, C. M. & Yang, C. R., 2017, In : Oncotarget. 8, 17, p. 27772-27785 14 p.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
National Cancer Institute (U.S.)